Figure 6.
![Event-free survival plots for 5-year outlook on the full cohort. Patients were stratified by the classifier using CLL-IPI variables (TP53 aberrations, IGHV mutational status, B2M level, clinical stage, and age [IPI]) (A,C,E,G) and addition of (para)clinical variables to the CLL-IPI variables (+BL) (B,D,F,H). Overall survival (A-B), treatment-free survival (C-D), treatment and infection–free survival (E-F), and infection-free survival (G-H). HR, hazard ratio.](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/6/12/10.1182_bloodadvances.2021006351/3/advancesadv2021006351f6.png?Expires=1736056924&Signature=LAycV~AOhnJnpGJJMARgItTrhESRfl0U0wBWzolJqpyJE3ZrZfJlsI95KbkHvUk43pWpVfNBQQpq73UC~NOA0doOMJvfMklTfnT~58MuYgQ-KGyMPi46pyXL8O7Hz6f-JS5we13EPpODc9dBJ8sasMZQdbfqSMjsDmRCF6gqnNoKI0bhBk~5orv~I0gTVOTQRTtWgTyxfwRLijGymWiz0yCkRL-nAd8lgWffUcRFN06tgB3bO4y56FHhTTQ3c3A9WTxYjLy4U2gYJ55Pt8Sw61EPBypc8J8MpHvOC733ANWUHFRU7iCz~y0Yz1HsU35AHxZi0OMQH~0dCs5P75FsMw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Event-free survival plots for 5-year outlook on the full cohort. Patients were stratified by the classifier using CLL-IPI variables (TP53 aberrations, IGHV mutational status, B2M level, clinical stage, and age [IPI]) (A,C,E,G) and addition of (para)clinical variables to the CLL-IPI variables (+BL) (B,D,F,H). Overall survival (A-B), treatment-free survival (C-D), treatment and infection–free survival (E-F), and infection-free survival (G-H). HR, hazard ratio.